| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |